GENERALIZED LIPODYSTROPHY
Clinical trials for GENERALIZED LIPODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED LIPODYSTROPHY trials appear
Sign up with your email to follow new studies for GENERALIZED LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug could help rare fat disorder patients
Disease control Recruiting nowThis study tests a new drug called mibavademab for people with generalized lipodystrophy, a rare condition where the body lacks fat tissue. The goal is to see if the drug can improve blood sugar, lower blood fats, and reduce liver fat. About 28 children and adults will take part …
Matched conditions: GENERALIZED LIPODYSTROPHY
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for youngest kids with rare fat disorder
Disease control Recruiting nowThis study tests a drug called metreleptin in 15 children under 6 years old who have a rare disease called generalized lipodystrophy, which prevents the body from storing fat properly and often leads to diabetes and high triglycerides. The goal is to see if the drug can lower blo…
Matched conditions: GENERALIZED LIPODYSTROPHY
Phase: PHASE3 • Sponsor: Amryt Pharma • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC